ZIM Integrated Shipping Services (NYSE:ZIM) reported second-quarter 2026 revenue of $1.78 billion, up 9% year over year, with net income increasing to $64 million from $24 million.
Aurora Cannabis (NASDAQ:ACB) confirmed that Curaleaf Holdings has commenced an unsolicited takeover bid for all Aurora common shares, offering implied consideration of US$4 per share.
Analog Devices (NASDAQ:ADI) reported record fiscal third-quarter 2026 revenue of $4.02 billion, up 40% year over year, with growth led by Data Center and Industrial markets.
IQSTEL (NASDAQ:IQST) reported first-half 2026 revenue of $207 million, up about 59% year over year from approximately $130 million, with gross profit increasing 26% to about $4.8 million.
Merck (NYSE:MRK) and Moderna (NASDAQ:MRNA) announced positive Phase 3 results from the INTerpath-001 trial, with intismeran autogene combined with KEYTRUDA meeting its primary recurrence-free survival endpoint and key secondary distant metastasis-free survival endpoint in patients with resected stage IIB-IV melanoma.
Target (NYSE:TGT) reported second-quarter 2026 net sales of $26.5 billion, up 5.3% year over year, as comparable sales increased 3.8% with traffic growth of 3.6%.
TOYO (NASDAQ:TOYO) reported $118.2 million in second-quarter revenue driven by increased deliveries of solar products.
IDEAYA Biosciences (NASDAQ:IDYA) announced a clinical collaboration with Genentech to evaluate IDE892 with GDC-7035 (RG6620) in patients with MTAP-deleted, KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC).
Estée Lauder Companies (NYSE:EL) reported fiscal 2026 net sales of $15 billion, up 5% year over year, as organic sales increased 3% and adjusted operating margin expanded to 11.2%.
Lowe’s (NYSE:LOW) reported second-quarter 2026 sales of $26 billion, up from $24 billion, while net earnings held at $2.4 billion.
GET YOUR GRAFA EDGE NOW
Sign up free to unlock this feature
We'll switch on a 30-day Edge trial as a welcome gift
